190 related articles for article (PubMed ID: 23944042)
1. [Inhibitory effect of imperatorin and isoimperatorin on activity of cytochrome P450 enzyme in human and rat liver microsomes].
Cao Y; Zhong YH; Yuan M; Li H; Zhao CJ
Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(8):1237-41. PubMed ID: 23944042
[TBL] [Abstract][Full Text] [Related]
2. Effect of Naltrexone Hydrochloride on Cytochrome P450 1A2, 2C9, 2D6, and 3A4 Activity in Human Liver Microsomes.
AlRabiah H; Ahad A; Mostafa GAE; Al-Jenoobi FI
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):707-713. PubMed ID: 29744741
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450-mediated herb-drug interaction potential of Galgeun-tang.
Lee SY; Lee JY; Kang W; Kwon KI; Park SK; Oh SJ; Ma JY; Kim SK
Food Chem Toxicol; 2013 Jan; 51():343-9. PubMed ID: 23104244
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of potential herb-drug interactions based on the effect of Suxiao Jiuxin Pill on CYP450 enzymes and transporters.
Qiang T; Li Y; Wang K; Lin W; Niu Z; Wang D; Wang X
J Ethnopharmacol; 2021 Nov; 280():114408. PubMed ID: 34252529
[TBL] [Abstract][Full Text] [Related]
5.
Zhang N; Liu J; Chen Z; Dou W
Pharm Biol; 2019 Dec; 57(1):571-576. PubMed ID: 31456483
[No Abstract] [Full Text] [Related]
6. In vitro Inhibitory Effects of Isofraxidin on Human Liver Cytochrome P450 Enzymes.
Song X; Dong G; Zhou Y
Pharmacology; 2019; 103(3-4):120-127. PubMed ID: 30544127
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cytochrome P450 inhibition assays using human liver microsomes by a cassette analysis /LC-MS/MS.
Zambon S; Fontana S; Kajbaf M
Drug Metab Lett; 2010 Aug; 4(3):120-8. PubMed ID: 20642444
[TBL] [Abstract][Full Text] [Related]
8. Development of a method to determine cytochrome P450 1A2, 2C9, 2D6 and 3A4 activity sheep hepatic microsomes.
McBride GM; Soo JY; Varcoe T; Morrison JL; Wiese MD
J Pharmacol Toxicol Methods; 2020; 106():106934. PubMed ID: 33080390
[TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].
Shan W; Zhang Y; Zhu J; Shao Q; Fan X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):85-8. PubMed ID: 22741468
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the inhibition of eight major human cytochrome P450 isozymes by a probe substrate cocktail
Valicherla GR; Mishra A; Lenkalapelly S; Jillela B; Francis FM; Rajagopalan L; Srivastava P
Xenobiotica; 2019 Dec; 49(12):1396-1402. PubMed ID: 30747554
[TBL] [Abstract][Full Text] [Related]
11. High-throughput cytochrome P450 (CYP) inhibition screening via a cassette probe-dosing strategy. VI. Simultaneous evaluation of inhibition potential of drugs on human hepatic isozymes CYP2A6, 3A4, 2C9, 2D6 and 2E1.
Bu HZ; Magis L; Knuth K; Teitelbaum P
Rapid Commun Mass Spectrom; 2001; 15(10):741-8. PubMed ID: 11344532
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Herb-Drug Interaction of Synacinn™ and Individual Biomarker through Cytochrome 450 Inhibition Assay.
Ab Rahman NS; Abd Majid FA; Abd Wahid ME; Zainudin AN; Zainol SN; Ismail HF; Wong TS; Tiwari NK; Giri S; Bhargava V
Drug Metab Lett; 2018; 12(1):62-67. PubMed ID: 29542427
[TBL] [Abstract][Full Text] [Related]
13. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
Zhao XJ; Yokoyama H; Chiba K; Wanwimolruk S; Ishizaki T
J Pharmacol Exp Ther; 1996 Dec; 279(3):1327-34. PubMed ID: 8968357
[TBL] [Abstract][Full Text] [Related]
14. Effects of artemisinin antimalarials on Cytochrome P450 enzymes in vitro using recombinant enzymes and human liver microsomes: potential implications for combination therapies.
Ericsson T; Sundell J; Torkelsson A; Hoffmann KJ; Ashton M
Xenobiotica; 2014 Jul; 44(7):615-26. PubMed ID: 24400699
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes.
Wei J; Zhang H; Zhao Q
Pharm Biol; 2018 Dec; 56(1):363-367. PubMed ID: 30122094
[TBL] [Abstract][Full Text] [Related]
16. Effect of honokiol on cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in human liver microsomes.
Jeong HU; Kong TY; Kwon SS; Hong SW; Yeon SH; Choi JH; Lee JY; Cho YY; Lee HS
Molecules; 2013 Sep; 18(9):10681-93. PubMed ID: 24005963
[TBL] [Abstract][Full Text] [Related]
17. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
Doehmer J; Weiss G; McGregor GP; Appel K
Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
[TBL] [Abstract][Full Text] [Related]
18. Assessment of drug-drug interaction for silymarin.
Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
[TBL] [Abstract][Full Text] [Related]
19. In vitro inhibition of human liver cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT) enzymes by rose bengal: system-dependent effects on inhibitory potential.
Kazmi F; Haupt LJ; Horkman JR; Smith BD; Buckley DB; Wachter EA; Singer JM
Xenobiotica; 2014 Jul; 44(7):606-14. PubMed ID: 24405273
[TBL] [Abstract][Full Text] [Related]
20. Effects of Baoyuan decoction, a traditional Chinese medicine formula, on the activities and mRNA expression of seven CYP isozymes in rats.
Lu YY; Du ZY; Li Y; Wang JL; Zhao MB; Jiang Y; Guo XY; Tu PF
J Ethnopharmacol; 2018 Oct; 225():327-335. PubMed ID: 30048731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
